In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...
The billionaire family that owns Purdue Pharma ... saga involving the pharmaceutical company that earned billions of dollars from the blockbuster painkiller OxyContin as sales representatives ...
The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...
The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end the ...